688189 南新制药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产140,793-3.02%145,180163,557184,895200,731
在建工程4,9040.00%4,904353573240
无形资产86,482-2.69%88,872143,135124,284138,006
商誉0--0010,84510,845
其他非流动资产178,8894.80%170,689137,043126,928108,614
411,0670.35%409,645444,089447,525458,436

流动资产
货币资金278,087-7.77%301,519490,270665,761713,472
应收账款29,640-17.74%36,034195,598508,716728,193
存货42,18117.57%35,87661,16730,36627,015
其他流动资产25,726-2.55%26,39831,31555,06327,492
375,634-6.05%399,827778,3501,259,9061,496,172

流动负债
短期借款10,000-0.30%10,030218,187322,950488,733
应付票据0--0000
应付帐款29,3447.75%27,23339,59139,54837,496
其他流动负债49,443-12.11%56,25882,07565,538122,127
88,787-5.06%93,521339,853428,035648,355
流动资产净值286,848-6.35%306,306438,497831,870847,817
资产总额减流动负债697,915-2.52%715,951882,5861,279,3961,306,253

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债3,414-3.61%3,5424,2805,7689,881
3,414-3.61%3,5424,2805,7689,881

总权益
    实收股本274,4000.00%274,400274,400274,400196,000
    储备项目492,798-3.21%509,150662,1921,018,6971,118,365
股东权益767,198-2.09%783,550936,5921,293,0971,314,365
非控股权益(72,697)2.19%(71,141)(58,286)(19,470)(17,993)